Novel Tetrazole-Based Antimicrobial Agents Targeting Clinical Bacteria Strains: Exploring the Inhibition of Staphylococcus aureus DNA Topoisomerase IV and Gyrase
Roszkowski, P.; Szymańska-Majchrzak, J.; Koliński, M.; Kmiecik, S.; Wrzosek, M.; Struga, M.; Szulczyk, D. Novel Tetrazole-Based Antimicrobial Agents Targeting Clinical Bacteria Strains: Exploring the Inhibition of Staphylococcus aureus DNA Topoisomerase IV and Gyrase. Int. J. Mol. Sci. 2022, 23, 378. https://doi.org/10.3390/ijms23010378
Roszkowski P, Szymańska-Majchrzak J, Koliński M, Kmiecik S, Wrzosek M, Struga M, Szulczyk D. Novel Tetrazole-Based Antimicrobial Agents Targeting Clinical Bacteria Strains: Exploring the Inhibition of Staphylococcus aureus DNA Topoisomerase IV and Gyrase. International Journal of Molecular Sciences. 2022; 23(1):378. https://doi.org/10.3390/ijms23010378
Chicago/Turabian StyleRoszkowski, Piotr, Jolanta Szymańska-Majchrzak, Michał Koliński, Sebastian Kmiecik, Małgorzata Wrzosek, Marta Struga, and Daniel Szulczyk. 2022. "Novel Tetrazole-Based Antimicrobial Agents Targeting Clinical Bacteria Strains: Exploring the Inhibition of Staphylococcus aureus DNA Topoisomerase IV and Gyrase" International Journal of Molecular Sciences 23, no. 1: 378. https://doi.org/10.3390/ijms23010378